European Archives - Page 332 of 1234 - European Medical Journal

Stroke Risk Rises in Children with Sickle Cell Disease

Despite established guidelines, new research has shown that the rate of ischemic stroke in children with sickle cell disease in California has risen.

4 Oct 2024

On-Demand Treatment Gaps in HAE

Explore our interactive article addressing delays in HAE on-demand treatment with expert views presented at EAACI 2024.

Haemorrhages More Common and Deadly in Patients With Cancer

A recent study has found that haemorrhages are far more frequent in cancer patients than previously believed, posing a serious threat to their prognosis and overall survival

Premature Ovarian Insufficiency Linked to Increased Autoimmune Disease Risk

In a study that tracked 3,972 women diagnosed with spontaneous POI and 15,708 matched controls, the prevalence of autoimmune disorders was notably higher in those with POI

Study Identifies Key Gut Bacteria in Newborns

A major study on UK newborns has revealed three distinct gut microbiome profiles, potentially paving the way for the development of personalised probiotic therapies

Interview: Sara Tolaney

Sara Tolaney – I started having an interest in medicine from a young age. Part of what drove my interest was having various family members…

Real-World Evidence of Hypertrophic Cardiomyopathy and Mavacamten

George Cooper is joined by Perry Elliott, Professor of Cardiovascular Medicine at University College London, UK, and Anjali Owens…

4 Oct 2024

The Unspeakable Disease: A Tale of Two Siblings

The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…

Ultrasound Achieves 96% Sensitivity in Detecting Postmenopausal Ovarian Cancer

Ovarian cancer is a global challenge, with most cases diagnosed late. The IOTA ADNEX model offers high sensitivity for earlier detection, but managing false positives is crucial.

world in hands

Gilead expands access to PrEP HIV candidate in 120 countries

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts